about
Human T regulatory cell therapy: take a billion or so and call me in the morningAdoptive T cell therapy for cancer in the clinicT cell receptor mimic antibodies for cancer therapyStrategies and Advancements in Harnessing the Immune System for Gastric Cancer ImmunotherapyInvestigative and clinical applications of synthetic immune synapsesFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsNovel immunotherapeutic strategies of gastric cancer treatmentA novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapyDistinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cellsTargeted immune therapy of ovarian cancerThe Intercellular Metabolic Interplay between Tumor and Immune CellsTrafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cellsCancer immunotherapy comes of ageVirus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaAntitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies.Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival.NKG2D CARs as cell therapy for cancer.Chimeric NKG2D T cells require both T cell- and host-derived cytokine secretion and perforin expression to increase tumor antigen presentation and systemic immunity.A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors.Human CD8 T cells generated in vitro from hematopoietic stem cells are functionally mature.Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression.Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cellsImmunotherapy for pediatric cancer.Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systemsGeneration of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.Improving the safety of cell therapy with the TK-suicide geneAdoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.Clinical applications of gamma delta T cells with multivalent immunity.Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.Nanoengineering of Immune Cell Function.The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapyThe construction of chimeric T-Cell receptor with spacer base of modeling study of VHH and MUC1 interaction.Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.Gastric cancer and the epoch of immunotherapy approachesAntigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.
P2860
Q24656069-E512B323-B34C-4EC6-BC83-537C9D74A4B7Q24680405-BD697BF2-13B6-4DD7-8371-A988C4168ED2Q26768271-0989D8DB-385C-4AAC-84B0-D34D75DBC02FQ26823515-DF36108F-FCA8-41C1-9B32-1D03816F3B6FQ26825315-A0E7C248-FFC5-4AAC-8716-2FA20D58605FQ26865532-0037C671-34BB-47F7-9ED9-18DEDF662A31Q27011232-5903F95A-F9A4-47FA-8745-FBD61C632CACQ27308798-E2823BCE-4F9A-41F8-8AD6-104FD75D7D9BQ27438176-A6EF65A4-E67B-4663-BEDE-002BB7012F7BQ28082828-0BA5E0F5-B127-4D02-8E17-F4BD9886C863Q28391079-44CAE791-BF05-4718-8D7D-6633D4E60183Q28732041-ED00F797-1064-4AAB-BBDC-E04BDAEE6473Q29619918-063E607B-584C-41FC-81A7-371E8E4BBE6EQ29622835-5803B33F-3F5C-44EF-A343-861D71AE9E9AQ33357299-4D9DD984-882E-4FF8-9341-D61FAC230F2DQ33426409-4FA7CCC7-75F9-49C9-9409-9A2D00D2E3D1Q33555573-760D9781-853E-4A38-B94B-598A32FF9533Q33584997-1DFA69AF-DB8C-415D-87E3-80B5FD5F3DC1Q33595873-150625B0-3CD4-40BD-B856-3B5FB9989FA2Q33671322-20A98F8E-27D4-4DDE-837F-D2DA077D78F9Q33803754-1D5390FC-56FC-493C-BFFC-F312C2A2521FQ33853349-9EB5A79F-EDF4-4492-A505-94400764F1AFQ33903025-76556A73-8380-4DB3-BEBD-A85B4699E269Q33911139-9A4601F4-A675-40A9-A00C-C783DB0FF18FQ33924586-F89F7588-9266-454E-A78B-FC1357062001Q33928557-3183BE8A-6C56-4960-B51B-FA925D028D90Q34122445-487A15D2-4794-439D-A3EB-6A03EAEAAFEDQ34163218-FA01463E-28FC-49EF-AB72-54C7EEDE0265Q34473451-DD0F07EA-1D6D-46C0-82CA-083E71AE488BQ34477411-638930EF-3B28-4FE6-89F0-D080033B37F9Q34590434-FEC6A6B7-A1EB-4865-9551-2D70480B025FQ34677859-F7E49843-8360-497A-A4E8-B73D1DB050B9Q34681856-2FF9CB14-C3BF-47C8-B521-76F0A1930501Q34953973-AD756400-06A8-44B6-BEC9-26C0BE57A712Q35044159-2B997081-25CA-47E3-9EFE-0A1CF3F06ECCQ35176505-6B83B9C0-EA0D-49AF-8F5D-A6C3AB8DF2B3Q35437978-4DF75B24-09CB-4B5E-AFD2-09B4CBF75A57Q35550879-82DC73B8-AF70-4FE4-978F-752B46629DD1Q35625349-1864C578-B8DD-47FE-B7AA-9F4FD13C53EEQ35641516-61E32429-9018-412B-A31F-1ED15692BE6B
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Principles of adoptive T cell cancer therapy.
@ast
Principles of adoptive T cell cancer therapy.
@en
Principles of adoptive T cell cancer therapy.
@nl
type
label
Principles of adoptive T cell cancer therapy.
@ast
Principles of adoptive T cell cancer therapy.
@en
Principles of adoptive T cell cancer therapy.
@nl
prefLabel
Principles of adoptive T cell cancer therapy.
@ast
Principles of adoptive T cell cancer therapy.
@en
Principles of adoptive T cell cancer therapy.
@nl
P2860
P356
P1476
Principles of adoptive T cell cancer therapy.
@en
P2093
Carl H June
P2860
P304
P356
10.1172/JCI31446
P407
P577
2007-05-01T00:00:00Z